| UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE | None | ||
| 0.0625MG;0.025MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| ANORO ELLIPTA is a combination of umeclidinium, an anticholinergic, and vilanterol, a long-acting beta2-adrenergic agonist (LABA), indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). | |||
|
Yes
| |||
| ANORO ELLIPTA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | ||||||||||||||||||||||||||
| ********** ************* ******** *********** | ******* *** *** **** * ********** ********* | ******* *** *** **** * ********** ********* | ********** ********* | ********** ********* | ********** ********* | ********** ********* | ********** ********* | ******** *** *** ** ********** ********* | ******** *** *** ** ********** ********* | ********** ********* | ********** ********* | ********** ********* | ********** ********* | ************ ** * ********** ******** ********** *** * ****-* ************** ******* | ************ ** * ********** ******** ********** *** * ****-* ************** ******* | ************ ** * ********** ******** ********** *** * β-* ************** ******* | ********** ****** | ********** ******* *** ********** **************** *********** *** *** ********* ** *********** ******** | **************** *********** *** ********* ** *********** ******** | **************** *********** *** ********* ** *********** ******** | ********** ************* ******** *********** | ********** ************* ******** *********** | **************** *********** *** ********* ** *********** ******** | ********** ************* ******** *********** | **************** *********** *** ********* ** *********** ******** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|